Navigation Links
Pfizer shows support for open access
Date:5/5/2009

Pfizer today announced details of a membership agreement with BioMed Central to cover publication costs for research articles published by its researchers.

Pfizer's BioMed Central membership arrangement means that Pfizer will centrally cover the publication fees for any researcher employed or funded by Pfizer when they submit a research article to one of BioMed Central's 190+ peer-reviewed open access journals. By funding open access publication fees in this way, Pfizer aims to make it as straightforward as possible for its researchers to make their research results universally accessible.

Matthew Cockerill, BioMed Central's Managing Director, noted "Many of the world's largest government and private research funders, including the National Institutes of Heath, the Howard Hughes Medical Institute and the Wellcome Trust, have already put in place policies to ensure open access to the results of the their research funding. This new agreement between BioMed Central and Pfizer demonstrates that the pharmaceutical industry also recognizes the benefits of open access."


'/>"/>

Contact: Matt McKay
matthew.mckay@biomedcentral.com
44-020-319-22216
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. Pfizer supports open access publishing for researchers in low-income countries
2. Pfizer inks global license to Genomatix Software and databases
3. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
4. New technology shows promise against resistant staph infections
5. Satellite imagery shows fragile Wilkins Ice Shelf destabilized
6. Microparticle immune response modifier shows broad effects against recurrent or metastatic cancer
7. Lab study shows THC exposure as adolescents linked to negative effects of THC as adults
8. New drug shows promise in treating drug-resistant prostate cancer
9. Novel lung cancer vaccine shows promise in fighting early-stage lung cancer
10. Brain building: Study shows brain growth tied to cell division in mouse embryos
11. Scots and Irish at greater risk of drink-related death, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
Breaking Biology Technology: